Author:
Scheithauer W.,Kornek G.V.,Raderer M.,Schüll B.,Schmid K.,Längle F.,Huber H.
Reference21 articles.
1. Where do we stand with 5-fluorouracil?;Schmoll;Semin Oncol,1999
2. New drugs in colorectal cancer: a review of antitumor activity and cross-resistance patterns of topoisomerase I inhibitors, thymidilate synthetase inhibitors, and oxaliplatin;Harstrick;Onkologie,1998
3. The medical treatment of colorectal cancer: actual status and new developments;Van Cutsem;Hepatogastroenterology,1999
4. Antitumor activities of a novel fluoropyrimidine, 4N-pentyloxycarbonyl-5-deoxa-5-fluorocytidine (capecitabine);Ishikawa;Biol Pharm Bull,1998
5. Preferential activation of capecitabine in tumor following oral administration in colorectal cancer patients;Schüller;Cancer Chemother Pharmacol,2000
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献